Federation Des Caisses Desjardins Du Quebec Eli Lilly & CO Transaction History

Federation Des Caisses Desjardins Du Quebec

$18.9 Billion
Q3 2024

A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Eli Lilly & CO stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 32,715 shares of LLY stock, worth $25.8 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

32,715

Previous 36,455 10.26%

Holding current value

$25.8 Million

Previous $33 Million 12.19%

% of portfolio

0.15%

Previous 0.19%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $2.89 Million - $3.59 Million	-3,740 Reduced 10.26%	32,715 $29 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $9.45 Million - $11.9 Million	13,036 Added 55.66%	36,455 $33 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $13.9 Million - $18.6 Million	23,419 New	23,419 $17.4 Billion
Q4 2023 Aug 14, 2024	SELL	$525.19 - $619.13 $1.45 Million - $1.71 Million	-2,768 Reduced 17.07%	13,452 $7.84 Billion
Q3 2023 Aug 14, 2024	SELL	$434.7 - $599.3 $615,969 - $849,208	-1,417 Reduced 8.03%	16,220 $8.71 Billion
Q2 2023 Aug 14, 2024	SELL	$350.74 - $468.98 $213,600 - $285,608	-609 Reduced 3.34%	17,637 $8.27 Billion
Q1 2023 Aug 14, 2024	BUY	$310.63 - $364.82 $703,576 - $826,317	2,265 Added 14.17%	18,246 $6.27 Billion
Q4 2022 Aug 14, 2024	SELL	$321.55 - $374.67 $57,235 - $66,691	-178 Reduced 1.1%	15,981 $5.85 Billion
Q3 2022 Aug 14, 2024	BUY	$296.48 - $337.87 $468,734 - $534,172	1,581 Added 10.85%	16,159 $5.23 Billion
Q2 2022 Aug 14, 2024	BUY	$278.73 - $327.27 $32,611 - $38,290	117 Added 0.81%	14,578 $4.73 Billion
Q1 2022 Aug 14, 2024	SELL	$234.69 - $291.66 $5.16 Million - $6.41 Million	-21,994 Reduced 60.33%	14,461 $4.14 Billion
Q4 2021 Aug 30, 2024	SELL	$224.85 - $279.04 $42,496 - $52,738	-189 Reduced 1.27%	14,667 $4.05 Billion
Q3 2021 Aug 30, 2024	BUY	$221.6 - $272.71 $424,364 - $522,239	1,915 Added 14.8%	14,856 $3.43 Billion
Q2 2021 Aug 30, 2024	SELL	$180.55 - $233.54 $4.25 Million - $5.49 Million	-23,514 Reduced 64.5%	12,941 $2.97 Billion
Q1 2021 Aug 30, 2024	SELL	$164.32 - $212.72 $526,645 - $681,767	-3,205 Reduced 14.14%	19,461 $3.64 Billion
Q4 2020 Aug 30, 2024	BUY	$130.46 - $172.63 $1.53 Million - $2.03 Million	11,731 Added 107.28%	22,666 $3.83 Billion
Q3 2020 Aug 30, 2024	SELL	$146.22 - $169.13 $2.3 Million - $2.66 Million	-15,755 Reduced 59.03%	10,935 $1.62 Billion
Q2 2020 Aug 30, 2024	BUY	$136.42 - $164.18 $413,079 - $497,137	3,028 Added 12.8%	26,690 $4.39 Billion
Q1 2020 Aug 30, 2024	SELL	$119.05 - $147.35 $1.57 Million - $1.94 Million	-13,158 Reduced 35.74%	23,662 $3.3 Billion
Q4 2019 Aug 30, 2024	BUY	$106.92 - $132.43 $19,245 - $23,837	180 Added 0.49%	36,820 $4.84 Billion
Q3 2019 Aug 30, 2024	SELL	$106.79 - $116.16 $115,119 - $125,220	-1,078 Reduced 2.86%	36,640 $4.1 Billion
Q2 2019 Aug 30, 2024	SELL	$110.79 - $129.32 $1.99 Million - $2.33 Million	-18,006 Reduced 32.31%	37,718 $4.17 Billion
Q1 2019 Aug 30, 2024	SELL	$111.31 - $131.02 $719,730 - $847,175	-6,466 Reduced 10.4%	55,724 $7.23 Billion
Q4 2018 Aug 30, 2024	BUY	$105.9 - $118.64 $2.73 Million - $3.05 Million	25,735 Added 70.59%	62,190 $7.2 Billion
Q3 2018 Aug 30, 2024	SELL	$85.86 - $107.31 $234,311 - $292,848	-2,729 Reduced 4.09%	64,063 $6.88 Billion
Q2 2018 Aug 30, 2024	SELL	$75.7 - $86.88 $17,411 - $19,982	-230 Reduced 0.34%	66,792 $5.71 Billion
Q1 2018 Aug 30, 2024	SELL	$74.21 - $87.6 $593 - $700	-8 Reduced 0.01%	67,022 $5.19 Billion
Q4 2017 Aug 30, 2024	SELL	$81.94 - $87.89 $4.04 Million - $4.34 Million	-49,333 Reduced 42.4%	67,030 $5.65 Billion
Q3 2017 Aug 30, 2024	SELL	$77.07 - $85.54 $2.04 Million - $2.27 Million	-26,509 Reduced 18.55%	116,363 $9.97 Billion
Q2 2017 Aug 30, 2024	BUY	N/A	49,372 Added 52.8%	142,872 $11.8 Billion
Q1 2017 Aug 30, 2024	BUY	N/A	57,045	93,500 $7.86 Billion

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account

Federation Des Caisses Desjardins Du Quebec Eli Lilly & CO Transaction History